Article
Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment.
Journal of viral hepatitis - 1 Jun 2022
Khera Tanvi, Madsen Lone Wulff, Du Yanqin, Lillevang Søren Thue, Christensen Peer Brehm, Wedemeyer Heiner
Abstract excerpt
Soluble inflammatory mediators (SIM) can be predictive of treatment outcome in antiviral treatment of chronic hepatitis C. Recently, it was shown that a subgroup of patients can be cured with four weeks of therapy. We here profiled patients for 70 SIM before and during treatment of hepatitis C with glecaprevir/pibrentasvir (GLE/PIB) +/- ribavirin. Proximity extension assay was performed in a total of 32 patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.